Business Results First Six Months of the Fiscal Year Ending March 31, 2026

from the beginning

Business Results First Six Months of the Fiscal Year Ending March 31,2026

Disclaimer

• Index

1. Executive Summary

• Executive Summary(1)

• Executive Summary(2)

2. Business results, First Six Months of the Fiscal Year Ending March 31, 2026

• Financial Highlights (Year on Year)

• Q2 Performance (Vs. Q1)

• Breakdown of Net Sales (by Business and Field)

• Breakdown of Net Sales (by Destination and Product Type)

• Information by Destination (Americas)

• Information by Destination (EMEA)

• Information by Destination (China)

• The Business Environment in China

• Outlooks for this Fiscal year in China

• Information by Destination (AP)

• Information by Destination (Japan)

• Breakdown of Operating Profit (Year on Year)

• Breakdown of Changes in the Consolidated Statement of Financial Position

• Consolidated Cash Flows

3. Growth Strategy Progress

• Market Expansion in the Clinical Chemistry Field

• Objectives of Acquiring the Clinical Chemistry Testing Business from JEOL

• Business Expansion Image in Clinical Chemistry

• Three Growth Strategies: Emerging Market Strategies

• Strategic Initiatives in India

• Three Growth Strategies: Expansion of New Businesses (Medical Robotics Business)

4. Financial Forecast for the Fiscal Year Ending March 31, 2026

• Revised Financial Forecast for the Fiscal Year Ending March 31, 2026

• Financial Forecast for the Fiscal Year Ending March 31, 2026 (Sales by Business, Field, and Destination)

• Dividend Forecast

• Toward the Fiscal Year Ending March 31, 2027

(Appendux)

• Topocs(July-October 2025)

• Published the Sysmex Report 2025 and the Sysmex Sustainability Data Book 2025

Together for a better healthcare journey